Charles H. Yoon

14.8k total citations
45 papers, 1.9k citations indexed

About

Charles H. Yoon is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Charles H. Yoon has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 22 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Charles H. Yoon's work include Cancer Immunotherapy and Biomarkers (10 papers), Cutaneous Melanoma Detection and Management (9 papers) and Melanoma and MAPK Pathways (8 papers). Charles H. Yoon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Cutaneous Melanoma Detection and Management (9 papers) and Melanoma and MAPK Pathways (8 papers). Charles H. Yoon collaborates with scholars based in United States, Germany and Australia. Charles H. Yoon's co-authors include Paul W. Sternberg, Gregg D. Jongeward, Junho Lee, Jason W. Pyrdol, Yoshinaga Ito, Adrienne Luoma, Lucas Ferrari de Andrade, Kai W. Wucherpfennig, Guo‐Cheng Yuan and Jason S. Gold and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

Charles H. Yoon

43 papers receiving 1.9k citations

Peers

Countries citing papers authored by Charles H. Yoon

Since Specialization

Citations

This map shows the geographic impact of Charles H. Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H. Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H. Yoon more than expected).

Fields of papers citing papers by Charles H. Yoon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles H. Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H. Yoon. The network helps show where Charles H. Yoon may publish in the future.

Co-authorship network of co-authors of Charles H. Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Charles H. Yoon. A scholar is included among the top collaborators of Charles H. Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles H. Yoon. Charles H. Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell–Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma 2025 ·Cancer Immunology Research ·F. Stephen Hodi, Anita Giobbie‐Hurder, Kwasi Adu‐Berchie, (unknown), Ana Lako, Mariano Severgnini, Emily M. Thrash, Jason L. Weirather, Joanna Bagińska, Michael P. Manos, Edward J. Doherty, Alexander Stafford, Heather Daley, Jerome Ritz, Patrick A. Ott, Kathleen L. Pfaff, Scott J. Rodig, Charles H. Yoon, Glenn Dranoff, David Mooney	5
2	Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial 2025 ·Annals of Surgical Oncology ·Charles H. Yoon, Merrick I. Ross, Brian Gastman, Jason J. Luke, Paolo A. Ascierto, Georgina V. Long, Piotr Rutkowski, Muhammad A. Khattak, Michele Del Vecchio, Luis de la Cruz‐Merino, Jacek Mackiewicz, Vanna Chiarion‐Sileni, Dirk Schadendorf, Matteo S. Carlino, Yujie Zhao, Mizuho Fukunaga‐Kalabis, Clemens Krepler, Alexander Eggermont, (unknown), Vernon K. Sondak	2
3	High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance 2024 ·SHILAP Revista de lepidopterología ·Yu‐Hwa Huang, Charles H. Yoon, Amit Gandhi, (unknown), Carlos Castrillón, Yasuyuki Kondo, Xi Lin, Walter Kim, Chao Yang, (unknown), Michael C. Carroll, Scott D. Gray‐Owen, Duane R. Wesemann, Charles G. Drake, Monica M. Bertagnolli, Nicole Beauchemin, Richard S. Blumberg	6
4	Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence 2024 ·Cancer ·Kevin X. Liu, (unknown), Manisha Thakuria, Jonathan D. Schoenfeld, Roy B. Tishler, Ann W. Silk, Charles H. Yoon, (unknown), Danielle N. Margalit	0
5	EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade 2023 ·Cancer Immunology Research ·Saba Tabasum, Dinesh Thapa, Anita Giobbie‐Hurder, Jason L. Weirather, Marco Campisi, (unknown), Xiaoyu Li, (unknown), Charles H. Yoon, Michael P. Manos, David A. Barbie, F. Stephen Hodi	13
6	Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response 2022 ·Immunity ·Sophia Liu, J. Bryan Iorgulescu, Shuqiang Li, (unknown), Irving Barrera, Vignesh Shanmugam, (unknown), Julia W. Morriss, (unknown), Evan Murray, David A. Reardon, Charles H. Yoon, David A. Braun, Kenneth J. Livak, Catherine J. Wu, Fei Chen	79
7	Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma 2022 ·Radiotherapy and Oncology ·Kevin X. Liu, (unknown), Jonathan D. Schoenfeld, Roy B. Tishler, Andrea K. Ng, Phillip M. Devlin, (unknown), Guilherme Rabinowits, Glenn J. Hanna, Ann W. Silk, Charles H. Yoon, Manisha Thakuria, Danielle N. Margalit	6
8	An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes 2022 ·Cancer Cell ·(unknown), Akanksha Verma, Ruth Dannenfelser, Marit M. Melssen, Itay Tirosh, Benjamin Izar, Tae‐Gyun Kim, Christopher J. Nirschl, K. Sanjana P. Devi, Walter C. Olson, Craig L. Slingluff, Víctor H. Engelhard, Levi A. Garraway, Aviv Regev, Kira Minkis, Charles H. Yoon, Olga G. Troyanskaya, Olivier Elemento, Mayte Suárez‐Fariñas, Niroshana Anandasabapathy	39
9	Inhibition of MICA and MICB Shedding Elicits NK-Cell–Mediated Immunity against Tumors Resistant to Cytotoxic T Cells 2020 ·Cancer Immunology Research ·Lucas Ferrari de Andrade, Sushil Kumar, Adrienne Luoma, Yoshinaga Ito, (unknown), Deng Pan, Jason W. Pyrdol, Charles H. Yoon, Kai W. Wucherpfennig	89
10	Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative radiation therapy 2020 ·Journal of the American Academy of Dermatology ·Fallon Chipidza, Manisha Thakuria, Jonathan D. Schoenfeld, Ann W. Silk, Paul J. Catalano, Charles H. Yoon, Glenn J. Hanna, James A. DeCaprio, Roy B. Tishler, Danielle N. Margalit	3
11	ATF-3 expression inhibits melanoma growth by downregulating ERK and AKT pathways 2020 ·Laboratory Investigation ·(unknown), Diana Wang, Shuyun Xu, Catherine Lee, (unknown), Charles H. Yoon, (unknown), Shuangshuang Wang, Natasha Y. Frank, Xunwei Wu, Christine G. Lian, Gëorge F. Murphy	14
12	Discovery of specialized NK cell populations infiltrating human melanoma metastases 2019 ·JCI Insight ·Lucas Ferrari de Andrade, Yuheng Lu, Adrienne Luoma, Yoshinaga Ito, Deng Pan, Jason W. Pyrdol, Charles H. Yoon, Guo‐Cheng Yuan, Kai W. Wucherpfennig	80
13	Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies 2019 ·Nature Communications ·Joan Montero, Cécile Gstalder, Daniel J. Kim, (unknown), Wayne Miles, Michael P. Manos, Justin Cidado, J. Paul Secrist, Adriana E. Tron, Keith T. Flaherty, F. Stephen Hodi, Charles H. Yoon, Anthony Letai, David E. Fisher, Rizwan Haq	42
14	Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity 2018 ·Science ·Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, Adrienne Luoma, Yoshinaga Ito, S Badrinath, Daphne Tsoucas, Bettina Franz, Kenneth F. May, Christopher J. Harvey, Sebastian Kobold, Jason W. Pyrdol, Charles H. Yoon, Guo‐Cheng Yuan, F. Stephen Hodi, Glenn Dranoff, Kai W. Wucherpfennig	337
15	Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab 2017 ·Journal for ImmunoTherapy of Cancer ·Raphael Brandão Moreira, Lana Hamieh, Evisa Gjini, Ana Lako, Katherine M. Krajewski, Charles H. Yoon, Patrick A. Ott	2
16	Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages 2016 ·OncoImmunology ·Bisweswar Nandi, Mia Shapiro, Mehmet Samur, Christine Pai, Natasha Y. Frank, Charles H. Yoon, Rao Prabhala, Nikhil C. Munshi, Jason S. Gold	62
17	Melanoma arising in a nevus of Ito: novel genetic mutations and a review of the literature on cutaneous malignant transformation of dermal melanocytosis 2015 ·Journal of Cutaneous Pathology ·Julie Y. Tse, (unknown), Hyemin Pomerantz, Charles H. Yoon, Elizabeth I. Buchbinder, Andrew E. Werchniak, Fei Dong, Christine G. Lian, Scott R. Granter	17
18	Immunity to the Vacuolar ATPase Complex Accessory Unit ATP6S1 in Patients with Malignant Melanoma 2014 ·Cancer Immunology Research ·Jun Zhou, (unknown), Xinqi Wu, Charles H. Yoon, Anita Giobbie‐Hurder, F. Stephen Hodi	3
19	Population-Based Outcome of Stage IA-IIA Resected Gastric Adenocarcinoma: Who Should Get Adjuvant Treatment? 2013 ·Annals of Surgical Oncology ·Jason S. Gold, (unknown), Mandeep S. Saund, Charles H. Yoon, Ashish Sharma, Qin Huang, (unknown), Edward E. Whang	6
20	LET‐23‐mediated signal transduction during Caenorhabditis elegans development 1995 ·Molecular Reproduction and Development ·Paul W. Sternberg, Giovanni Lesa, Junho Lee, Wendy S. Katz, Charles H. Yoon, Thomas R. Clandinin, Linda Huang, Helen Chamberlin, Gregg D. Jongeward	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact